Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acitretin Market

Acitretin Market Share

Report ID: GMI9236
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Acitretin Market Share

The acitretin industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Acitretin Market Companies

Some of the eminent market participants operating in the acitretin industry include:

Amneal Pharmaceuticals, Inc.
Biophore.
Chongqing Huapont Pharmaceutical Co., Ltd.
Globe International Limited
GSK Plc
Merck KGaA
Prasco Laboratories
SGPharma Pvt Ltd
Sionc Pharmaceuticals Pvt. Ltd.
Sun Pharma Industries Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acitretin market size was USD 33.8 million in 2023 and will register a 4.6% CAGR from 2024 to 2032, attributed to increasing healthcare expenditure, rising incidence of dermatological disorders, along with advancements in medical research and technology.

Demand for acitretin across hospital pharmacies recorded USD 21.7 million by 2032 due to pivotal role of hospitals in treating severe dermatological conditions like psoriasis, where acitretin is a crucial therapeutic option and their centralized distribution network.

North America acitretin industry size will record 4.4% CAGR up to 2032, driven by high prevalence rates of psoriasis and other dermatological conditions, robust healthcare infrastructure, and substantial investments in research and development.

Prominent companies including Amneal Pharmaceuticals, Inc., Biophore., Chongqing Huapont Pharmaceutical Co., Ltd., Globe International Limited, GSK Plc, Merck KGaA, Prasco Laboratories, SGPharma Pvt Ltd, Sionc Pharmaceuticals Pvt. Ltd., and Sun Pharma Industries Limited, are operating in the acitretin industry.